U.S. News — Best Lawyers’ 2021 edition named Goodwin the Biotechnology Law Firm of the Year for the sixth time. LMG Life Sciences also named Goodwin firm of the year for 2020 in the corporate, lifecycle, and intellectual property categories. Mergermarket’s Deal Drivers FY 20 reports named Goodwin the number one firm (by deal count) for Pharma, Medical, and Biotech M&A in North America and the number two firm (by value) for Pharma, Medical, and Biotech M&A in Europe, the Middle East, and Africa. Chambers UK 2021 recognized Goodwin’s Life Sciences UK practice for the first time in 2020 and The British Legal Awards named Goodwin’s UK team the Life Sciences Team of the Year in 2020.
Goodwin’s Life Sciences practice represents leading public and private life sciences companies and investors across their entire life cycles — including financings, capital market transactions, M&A, collaborations and licensing, intellectual property, and regulatory matters.